image
Axsome Therapeutics, Inc. AXSM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 93.17
-4.31 %
$ 4.52 B
Market Cap
-14.16
P/E
INCOME STATEMENT
271 M REVENUE
440.80%
Growth Rates
1Year 440.80%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-232 M OPERATING INCOME
-31.34%
Growth Rates
1Year -31.34%
3Years -32.73%
5Years -47.82%
7Years -35.57%
10Years -62.20%
-239 M NET INCOME
-27.84%
Growth Rates
1Year -27.84%
3Years -32.48%
5Years -50.52%
7Years -36.42%
10Years -60.07%
EFFICIENCY
Earnings Waterfall Axsome Therapeutics, Inc.
image
Revenue 271 M
Cost Of Revenue 26.1 M
Gross Profit 245 M
Operating Expenses 476 M
Operating Income -232 M
Other Expenses 7.41 M
Net Income -239 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
REVENUE
Revenue 270.6 50.0 0 0 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 26.1 5.2 1.2 77.7 K 37.3 K 48.9 K 42.6 K 20.5 K 3.54 K 0 0
Gross Profit 244.5 44.8 (1.2) 77.7 K 37.3 K 48.9 K 42.6 K 20.5 K 3.54 K 0 0
OPERATING INCOME
Operating Expenses 476.4 221.3 124.7 99.1 67.1 32.6 27.0 27.1 9.2 5.5 1.8
Selling, General and Administrative Expenses 323.1 159.3 66.6 28.9 13.6 9.4 7.2 6.3 2.4 1.4 0.3
Research and Development Expenses 97.9 57.9 58.1 70.2 53.6 23.5 20.0 21.2 6.8 4.3 1.5
Operating Income (231.8) (176.5) (124.7) (99.1) (67.2) (32.8) (27.2) (27.5) (9.2) (5.7) (1.8)
PRE-TAX INCOME
Interest Income Expense 6.5 7.3 5.7 2.6 1.2 1.1 1.3 0.1 0.9 2.2 0.3
Total Other Income (6.5) (7.3) (5.7) (3.8) (1.2) 1.7 (1.8) 0.3 (1.4) (0.3) (0.3)
Pre-Tax Income (238.3) (187.1) (130.4) (102.9) (68.3) (31.0) (28.9) (27.2) (10.6) (6.0) (2.2)
NET INCOME
Tax Provision 1.0 10.6 4.5 2.5 1.3 3.0 1.3 0.6 1.4 (2.4) (1.8)
Net Income (239.2) (197.8) (134.9) (105.4) (69.7) (31.0) (28.9) (27.2) (10.6) (6.0) (2.2)
EPS 5.27 4.86 3.59 2.83 2.05 1.15 1.27 1.42 0.88 0.47 0.17